Literature DB >> 16968413

Cardiovascular pharmacology and physiology of the isoprostanes.

Jean-Luc Cracowski1, Thierry Durand.   

Abstract

F(2)-isoprostanes are a complex family of compounds produced from arachidonic acid via a free radical-catalyzed mechanism. Their quantification as a pathophysiological biomarker provides a unique opportunity to investigate lipid peroxidation in vascular diseases. Their measurement also provides an interesting biomarker for the rational dose selection of antioxidants in vascular diseases where oxidative stress might be involved. In addition to their use as biomarkers, some isoprostanes possess a biological activity. The 15-series F(2)- and E(2)-isoprostanes mediate vasoconstriction in different vascular beds and species. In addition, 15-F(2t)-IsoP induces smooth muscle cells mitogenesis and monocyte adhesion to endothelial cells. The data available supports but does not prove the hypothesis that isoprostanes are involved in vascular physiology and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16968413     DOI: 10.1111/j.1472-8206.2006.00435.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  15 in total

1.  Greater γ-tocopherol status during acute smoking abstinence with nicotine replacement therapy improved vascular endothelial function by decreasing 8-iso-15(S)-prostaglandin F2α.

Authors:  Eunice Mah; Ruisong Pei; Yi Guo; Christopher Masterjohn; Kevin D Ballard; Beth A Taylor; Alan W Taylor; Maret G Traber; Jeff S Volek; Richard S Bruno
Journal:  Exp Biol Med (Maywood)       Date:  2014-10-30

2.  Tempol attenuates the exercise pressor reflex independently of neutralizing reactive oxygen species in femoral artery ligated rats.

Authors:  Jennifer L McCord; Hirotsugu Tsuchimochi; Katsuya Yamauchi; Anna Leal; Marc P Kaufman
Journal:  J Appl Physiol (1985)       Date:  2011-07-07

Review 3.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

4.  Biomarkers for cognitive aging part II: oxidative stress, cognitive assessments, and medication adherence.

Authors:  Kathleen C Insel; Ida M Moore; Amy N Vidrine; David W Montgomery
Journal:  Biol Res Nurs       Date:  2011-05-17       Impact factor: 2.522

Review 5.  Isoprostanes and asthma.

Authors:  Judith A Voynow; Apparao Kummarapurugu
Journal:  Biochim Biophys Acta       Date:  2011-05-08

Review 6.  Markers of oxidant stress that are clinically relevant in aging and age-related disease.

Authors:  Kimberly D Jacob; Nicole Noren Hooten; Andrzej R Trzeciak; Michele K Evans
Journal:  Mech Ageing Dev       Date:  2013-02-18       Impact factor: 5.432

7.  Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study.

Authors:  Thomas M Tadros; Joseph M Massaro; Guido A Rosito; Udo Hoffmann; Ramachandran S Vasan; Martin G Larson; John F Keaney; Izabella Lipinska; James B Meigs; Sekar Kathiresan; Christopher J O'Donnell; Caroline S Fox; Emelia J Benjamin
Journal:  Obesity (Silver Spring)       Date:  2009-10-29       Impact factor: 5.002

Review 8.  Targeted chiral lipidomics analysis of bioactive eicosanoid lipids in cellular systems.

Authors:  Seon Hwa Lee; Ian A Blair
Journal:  BMB Rep       Date:  2009-07-31       Impact factor: 4.778

Review 9.  Targeted quantitative analysis of eicosanoid lipids in biological samples using liquid chromatography-tandem mass spectrometry.

Authors:  Clementina Mesaros; Seon Hwa Lee; Ian A Blair
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-03-17       Impact factor: 3.205

10.  Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus.

Authors:  Jian-Xiong Chen; Patrick W O'Mara; Stanley D Poole; Naoko Brown; Noah J Ehinger; James C Slaughter; Bibhash C Paria; Judy L Aschner; Jeff Reese
Journal:  Pediatr Res       Date:  2012-08       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.